Market Tracker

01/19 4:39pm ET

Orexigen Therapeutics Inc (NASDAQ:OREX)

3.21
Delayed Data
As of Jan 19
 -0.27 / -7.76%
Today’s Change
1.65
Today|||52-Week Range
19.80
+84.48%
Year-to-Date

Today’s Trading

Previous close3.48
Today’s open3.48
Day’s range3.16 - 3.49
Volume354,689
Average volume (3 months)414,344
Market cap$50.8M
Dividend yield--
Data as of 4:00pm ET, 01/19/2017

Growth & Valuation

Earnings growth (last year)-62.50%
Earnings growth (this year)-31.82%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-55.95%
P/E ratioNM
Price/Sales9.22
Price/Book1.52

Competitors

 Today’s
change
Today’s
% change
MTEXMannatech Inc+0.23+1.23%
----
GLMDGalmed Pharmaceutica...+0.03+0.72%
APDNApplied DNA Sciences...+0.05+2.56%
Data as of 3:59pm ET, 01/19/2017

Financials

Next reporting dateMarch 15, 2017
EPS forecast (this quarter)-$1.58
Annual revenue (last year)$24.5M
Annual profit (last year)-$68.7M
Net profit margin-280.83%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Narachi
Chief Operating Officer &
Executive Vice President
Thomas R. Cannell
Corporate headquarters
La Jolla, California

Forecasts